About Our People Legal Stuff Careers
This image provided by Medtronic shows its MiniMed 670G system. Federal regulators have approved a first-of-a-kind "artificial pancreas," a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed. The device from Medtronic was approved Wednesday, Sept. 28, 2016, for patients with Type 1 diabetes, the kind usually diagnosed during childhood. (Medtronic via AP)

The FDA approved the world's first 'artificial pancreas' for people with Type 1 diabetes


The Food and Drug Administration is making huge strides to help patients manage Type 1 diabetes.

The FDA on Wednesday approved the first cellphone-sized device that takes care of of checking a patient's blood sugar and delivers lifesaving insulin as needed.

It acts as an "artificial pancreas" system -- monitoring blood sugar levels in the bloodstream and then delivering necessary background (also known as basal) insulin doses. 

The device will also shut off when blood sugar levels drop too low.

"This first-of-its-kind technology can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," said Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health.

There might not be a cure for diabetes just yet, but this device is definitely a huge leap forward.

60 Second Circa for Thursday AM, Sept. 29, 2016

WATCH  | For the news you need, check out our 60 Second Circa.

Read Comments
Facebook Twitter Instagram Pinterest Linked In List Menu Enlarge Gallery Info Menu Close Angle Down Angle Up Angle Left Angle Right Grid Grid Play Align Left Search Youtube Mail Mail Angle Down Bookmark